Previous studies have revealed the overexpression of mcm2 in cervical cancer by DNA microarray and transcriptional profiling [27], showing that mcm2 can be detected in various dysplastic and malignant processes, including cervical neoplasia related to high-risk HPV [28]. This evidence concerns the gene MCM2 and cervical carcinoma.